5mg tirzepatide vs semaglutide and key differences, weight loss results (2026) Subcutaneously administered tirzepatide vs semaglutide
Description
Prescribing information: TRULICITY (dulaglutide) injection, for subcutaneous use
Participants taking semaglutide experienced significantly fewer serious heart-related events alongside meaningful weight loss
Vincents University Hospital in Dublin, Ireland
This story is by Matt Toal
Such an error is most likely due to the omission of a trailing zero
the study mentioned earlier noted a higher incidence of thiamine deficiency at 12 months in GLP-1 RA users compared to those not on these drugs, although its not extremely common
